Behcet's disease: How to diagnose and treat vascular involvement

被引:128
作者
Seyahi, Emire [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Dept Med, Div Rheumatol, TR-81310 Istanbul, Turkey
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2016年 / 30卷 / 02期
关键词
Behcet's disease; Vasculitis; Thrombosis; Lower extremity vein thrombosis; Vena cava thrombosis; Pulmonary artery aneurysms; Azathioprine; Anticoagulation; BUDD-CHIARI-SYNDROME; PULMONARY-ARTERY INVOLVEMENT; GENE G20210A MUTATIONS; VENOUS THROMBOSIS; ANTICARDIOLIPIN ANTIBODIES; RETROSPECTIVE ANALYSIS; THROMBOPHILIC FACTORS; VEIN-THROMBOSIS; OUTCOME SURVEY; MANAGEMENT;
D O I
10.1016/j.berh.2016.08.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease is a multisystem disorder with unknown etiology and a unique geographic distribution. The disease is characterized by recurrent skin-mucosa lesions and sight-threatening panuveitis. Vascular involvement, which is more common and more severe among males, has also equally characteristic features such as affecting mostly veins, having a significant tendency for thrombosis, and running a relapsing course. Lower extremity vein thrombosis (LEVT) is the most frequent manifestation, followed by vena cava inferior thrombosis. Pulmonary artery involvement (PAI), the most common form of arterial involvement, manifests as aneurysms and "in situ" thrombosis. PAI and Budd Chiari syndrome are the leading causes of increased mortality. In vascular cluster, typically, several types of venous or arterial vascular involvement may accumulate in the same individual. LEVI or cerebral venous sinus thrombosis is often present in these subgroups as the first event. Immunosuppressive treatment is essential in preventing the attacks and increasing survival. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:279 / 295
页数:17
相关论文
共 78 条
[1]   Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation [J].
Ahn, Joong Kyong ;
Lee, You Sun ;
Jeon, Chan Hong ;
Koh, Eun-Mi ;
Cha, Hoon-Suk .
CLINICAL RHEUMATOLOGY, 2008, 27 (02) :201-205
[2]   Behcet Disease With Vascular Involvement Effects of Different Therapeutic Regimens on the Incidence of New Relapses [J].
Alibaz-Oner, Fatma ;
Karadeniz, Asli ;
Yilmaz, Sema ;
Balkarli, Ayse ;
Kimyon, Gezmis ;
Yazici, Ayten ;
Cinar, Muhammet ;
Yilmaz, Sedat ;
Yildiz, Fatih ;
Bilge, Sule Yasar ;
Bilgin, Emre ;
Coskun, Belkis Nihan ;
Omma, Ahmet ;
Cetin, Gozde Yildirim ;
Cagatay, Yonca ;
Karaaslan, Yasar ;
Sayarlioglu, Mehmet ;
Pehlivan, Yavuz ;
Kalyoncu, Umut ;
Karadag, Omer ;
Kasifoglu, Timucin ;
Erken, Eren ;
Pay, Salih ;
Cefle, Ayse ;
Kisacik, Bunyamin ;
Onat, Ahmet Mesut ;
Cobankara, Veli ;
Direskeneli, Haner .
MEDICINE, 2015, 94 (06) :e494
[3]  
Ambrose N, 2014, CLIN EXP RHEUMATOL, V32, pS99
[4]  
Arslan C, 2014, CLIN EXP RHEUMATOL, V32, pS109
[5]   Budd-Chiari syndrome: Etiology, pathogenesis and diagnosis [J].
Aydinli, Musa ;
Bayraktar, Yusuf .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (19) :2693-2696
[6]  
BERGMAN R, 1990, Journal of Dermatology (Tokyo), V17, P164
[7]   Major vessel involvement in Behcet's disease: an update [J].
Calamia, Kenneth T. ;
Schirmer, Michael ;
Melikoglu, Melike .
CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (01) :24-31
[8]  
Demirkesen C, 2010, BEHCET'S SYNDROME, P215, DOI 10.1007/978-1-4419-5641-5_13
[9]   Immunosuppressants reduce venous thrombosis relapse in Behcet's disease [J].
Desbois, A. C. ;
Wechsler, B. ;
Resche-Rigon, M. ;
Piette, J. C. ;
Huong, D. Le Thi ;
Amoura, Z. ;
Koskas, F. ;
Desseaux, K. ;
Cacoub, P. ;
Saadoun, D. .
ARTHRITIS AND RHEUMATISM, 2012, 64 (08) :2753-2760
[10]   Behcet's disease in budd-chiari syndrome [J].
Desbois, Anne Claire ;
Rautou, Pierre Emmanuel ;
Biard, Lucie ;
Belmatoug, Nadia ;
Wechsler, Bertrand ;
Resche-Rigon, Mathieu ;
Zarrouk, Virginie ;
Fantin, Bruno ;
de Chambrun, M. Pineton ;
Cacoub, Patrice ;
Valla, Dominique ;
Saadoun, David ;
Plessier, Aurelie .
ORPHANET JOURNAL OF RARE DISEASES, 2014, 9